| Literature DB >> 31859796 |
Ivone Jiménez Toro1, Carlos A Rodríguez1, Andrés F Zuluaga1.
Abstract
During the last decades, enterococci have emerged as important etiological agents in bacteremia, osteomyelitis, endocarditis and soft tissue infections. Antimicrobial combinations have been the most used therapeutic strategies for these infections, aiming for a bactericidal synergistic effect. However, besides in vitro and in vivo models, the clinical usefulness of such combinations is controversial, especially in non-endocardic systemic infections. For example, although beta-lactam and aminoglycoside combinations or double beta-lactam treatment have achieved high cure rates in endocarditis, the optimal treatment has not yet been clarified or if these combinations are useful in other infections. The aim of this review was to analyze and summarize the results from several experimental models of antienterococcal combined therapy and from clinical trials available in PubMed/Medline, to better assess the evidence that supports the use of these combinations. In conclusion, the available information is scarce, and more and better in vivo models and clinical studies are required to confirm the potential synergistic activity of antienterococcal combinations.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31859796 DOI: 10.4067/S0716-10182019000500556
Source DB: PubMed Journal: Rev Chilena Infectol ISSN: 0716-1018 Impact factor: 0.520